Indication

Brainstem Neoplasm

1 clinical trial

1 product

Clinical trial

A Phase 1 Study of Entinostat, an Oral Histone Deacetylase Inhibitor, in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Status: Completed, Estimated PCD: 2021-06-30

Product